Sky-high drug prices were supposed to deliver more innovation. That policy failed.
Is there data shows the number of new cancer drugs and their effectiveness since prices skyrocketed?
Little value from high-priced cancer care
Is there data shows the number of new cancer drugs and their effectiveness since prices skyrocketed?